Unlocking the Power of Global Capability Centers (GCCs) in Biopharma: Drive Efficiency, Innovation, and Scientific Excellence
As global biopharma companies face rising demands for efficiency, standardization, and scientific excellence, Global Capability Centers (GCCs) have emerged as a transformative solution. Our latest whitepaper, "Unlocking the Power of Global Capability Centers (GCCs) in Biopharma: Drive Efficiency, Innovation, and Scientific Excellence," explores how GCCs—especially those based in India—are reshaping how the industry manages scientific…...
Read MoreTop Stories
What’s Next for Global Capability Centers )?
The theme for this year’s NASSCOM GCC Summit, “The Next GCC...
MAPS 2025 Decoded: The Medical Affairs Playbook
At the MAPS Americas 2025 conference in New Orleans, one of...
Medical Affairs 2.0: GenAI as the Catalyst for
Digital and AI were hot topics underpinning many of the...
Filter
A 4-Step Plan to Drive HCP Engagement
HCPs are a time-constrained and hard-to-engage audience. Learn how pharma can digitally engage HCPs better...
Promoting Diversity and Inclusion in Clinical Trials – New England Journal of Medicine’s New Policy
Read this update on how the New England Journal of Medicine is trying to promote...
MedTech Summit 2021: Understanding Post Market Clinical Follow Up (PCMF)
An ideal PMCF plan, with reference to MDCG 2020-7, presents the general and specific methods...
Bringing New Devices to Market under the EU MDR
With the MDR coming into effect, the manufacturers should plan and construct their strategy to...
Digital Scientific Content: Stakeholder Perspectives
What do the different relevant stakeholder groups truly expect from pharma-generated scientific content?...
How Can Preprints Drive Trust in Science?
By tagging preprints with various indicators, badges may represent quality, rigor, and scope. In doing...